✦ LIBER ✦

Cotransplantation of Mesenchymal Stem Cells Might Prevent Death from Graft-versus-Host Disease (GVHD) without Abrogating Graft-versus-Tumor Effects after HLA-Mismatched Allogeneic Transplantation following Nonmyeloablative Conditioning

✍ Scribed by Frédéric Baron; Chantal Lechanteur; Evelyne Willems; France Bruck; Etienne Baudoux; Laurence Seidel; Jean-François Vanbellinghen; Kaoutar Hafraoui; Marie Lejeune; André Gothot; Georges Fillet; Yves Beguin

Book ID: 116281740
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 337 KB
Volume: 16
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2010.01.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mesenchymal Stem Cell Infusion As Preven

Mesenchymal Stem Cell Infusion As Prevention For Graft Rejection And Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning From HLA-Mismatched Donors: A Pilot Study

✍ F. Baron; E. Willems; C. Lechanteur; E. Baudoux; P. Frere; K. Hafraoui; G. Fille 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Bortezomib, tacrolimus, and methotrexate

Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors

✍ Koreth, J.; Stevenson, K. E.; Kim, H. T.; Garcia, M.; Ho, V. T.; Armand, P.; Cut 📂 Article 📅 2009 🏛 American Society of Hematology 🌐 English ⚖ 206 KB